Natera and Fractyl Health, biotech companies, traded on the NASDAQ stock exchange on September 1, 2026.

1 report, 1 independent Updated Sep 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Natera Nasdaq

Keep exploring

Part of

BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs. All 1 developments

The entities involved

Natera
company in San Carlos, United States
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
Nasdaq
American fully electronic stock exchange
- Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
- Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.Mon 16:28

Related events

Coverage

Newest first; wire copies grouped

Sep 1themarketsdaily.com